The U.S. cancer death rate dropped more than 2% between 2016 and 2017, the biggest single-year drop ever, according to the American Cancer Society. Better treatment for lung cancer is a factor.
Matching the sickest patients with social workers and medical support doesn't reduce costly hospital readmissions, a study finds. Still, some believe greater social investment could make a difference.
Both sides say they want the high court to quickly weigh in on a case that could invalidate the federal health law. Whatever the court decides will likely have consequences in 2020 elections.
People with sickle cell disease aren't fueling the opioid crisis, research shows. Yet some ER doctors still treat patients seeking relief for agonizing sickle cell crises as potential addicts.
The state now requires women and girls under 18 to obtain permission from their parents or a judge. But in a recent poll, most Massachusetts voters favored letting minors decide on their own.
Nearly 1 in 4 Americans has trouble affording prescription drugs, according to a Kaiser Family Foundation poll. Over the past decade, high prices of several medicines have become flashpoints.
Preparers of pills made from placental tissue have gained online momentum, claiming to support each new mom in her slog to recovery. A historian traces the trend to a mother's need to be heard.
Anger and fear have turned to pragmatic hope in the year since the people of Fort Scott, Kan., lost their hospital to corporate downsizing. A community health center remains. So far, so good.
NPR tells the exclusive, behind-the-scenes story of the first person with a genetic disorder to be treated in the United States with the revolutionary gene-editing technique CRISPR.